Dominant negative effect of a truncated erythropoietin receptor (EPOR- T) on erythropoietin-induced erythroid differentiation: Possible involvement of EPOR-T in ineffective erythropoiesis of myelodysplastic syndrome

Experimental Hematology

Volumn 27, Issue 2, 1999, Pages 229-233

  Shimizu, Ritsuko ^a   Komatsu, Norio ^a   Miura, Yasusada ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Erythropoiesis; Erythropoietin receptor; Myelodysplastic syndrome; UT 7

Indexed keywords

COMPLEMENTARY DNA; ERYTHROPOIETIN RECEPTOR; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL DIFFERENTIATION; ERYTHROPOIESIS; ERYTHROPOIETIN; GENES, DOMINANT; HUMANS; MYELODYSPLASTIC SYNDROMES; RECEPTORS, ERYTHROPOIETIN; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032998357     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(98)00048-4     Document Type: Article

References (25)

1. Krantz S.B. Erythropoietin. Blood. 77:1991;419.
2. Koury M.J. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science. 248:1990;378.
3. Nakamura Y., Komatsu N., Nakauchi H. A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science. 257:1992;1138.
4. Shimizu R., Komatsu N., Nakamura Y., Nakauchi H., Nakabeppu Y., Miura Y. Role of c-jun in the inhibition of erythropoietin receptor-mediated apoptosis. Biochem Biophys Res Commun. 222:1996;1.
5. Komatsu N., Kirito K., Shimizu R., Kunitama M., Yamada M., Uchida M., Takatoku M., Eguchi M., Miura Y. In vitro development of erythroid and megakaryocytic cells from a UT-7 subline, UT-7/GM. Blood. 89:1997;4021.
6. Komatsu N., Nakauchi H., Miwa A., Ishihara T., Eguchi M., Moroi M., Okada M., Sato Y., Wada H., Yawata Y., Suda T., Miura Y. Establishment and characterization of a human leukemic cell line with megakaryocytic features. dependency on granulocyte-macrophage colony-stimulating factor, interleukin-3, or erythropoietin for growth and survival Cancer Res. 51:1991;341.
7. Komatsu N., Kunitama M., Yamada M., Hagiwara T., Kato T., Miyazaki H., Eguchi M., Yamamoto M., Miura Y. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO. Blood. 87:1996;4552.
8. Bennet J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 51:1982;189.
9. Guimaraes J.E., Berney J.J., Francis G.E., Hoffbrand A.V. The identification of mixed granulocytic-erythrocytic colonies in vitro. Exp Hematol. 12:1984;535.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156.
11. Sellins K.S., Cohen J. Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J Immunol. 139:1987;3199.
12. Mosmann T. Rapid colorimetric assay for cellular growth and survival. application to proliferation and cytotoxicity assays J Immunol Methods. 65:1983;55.
13. Ponte P., Ng S.Y., Engel J., Gunning P., Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs. DNA sequence of a human beta-actin cDNA Nucleic Acids Res. 12:1984;1687.
14. Carroll M., Zhu Y., D'Andrea A.D. Erythropoietin-induced cellular differentiation requires prolongation of the G1 phase of the cell cycle. Proc Natl Acad Sci U S A. 92:1995;2869.
15. Krosl J., Damen J.E., Krystal G., Humphries R.K. Erythropoietin and interleukin-3 induce distinct events in erythropoietin receptor-expressing Ba/F3 cells. Blood. 85:1995;50.
16. Mundle S., Iftikhar A., Shetty V., Dameron S., Wright-Quinones V., Marcus B., Loew J., Gregory S., Raza A. Novel in situ double labeling for simultaneous detection of proliferation and apoptosis. J Histochem Cytochem. 42:1994;1533.
17. Raza A., Gezer S., Mundle S., Gao X.-Z., Alvi S., Borok R., Rifkin S., Iftikhar A., Shetty V., Parcharidou A., Loew J., Marcus B.et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood. 86:1995;268.
18. Lepelley P., Campergue L., Grardel N., Preudhomme C., Cosson A., Fenaux P. Is apoptosis a massive process in myelodysplastic syndrome? Br J Haematol. 95:1996;368.
19. Nakamura Y., Nakauchi H. Truncated erythropoietin receptor and cell death. a reanalysis Science. 264:1994;588.
20. Martelli F., Cenciarelli C., Santarelli G., Polikar B., Felsani A., Caruso M. MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene. 9:1994;3579.
21. Guo K., Wang J., Andres V., Smith R.C., Walsh K. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol. 15:1995;3823.
22. Skapek S.X., Rhee J., Spicer D.B., Lassar A.B. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science. 267:1995;1022.
23. Nakamura Y., Tokumoto Y., Nakauchi H. Role of a truncated erythropoietin receptor for erythroid differentiation. Biochem Biophys Res Commun. 218:1996;205.
24. Carroll M., Mathey-Prevot B., D'Andrea A. Differentiation domains of the erythropoietin receptor. Proc Soc Exp Biol Med. 205:1994;289.
25. Gobert S., Porteu F., Pallu S., Muller O., Sabbah M., Dusanter-Fourt I., Courtois G., Lacombe C., Gisselbrecht S., Mayeux P. Tyrosine phosphorylation of the erythropoietin receptor. role for differentiation and mitogenic signal transduction Blood. 86:1995;598.